Skip to main content

Seminar explores role of proteins in health and disease

July 16, 2013 By David Tenenbaum

The Human Proteomics Program at UW–Madison and the BioPharmaceutical Technology Center Institute on Aug. 1 will present the Wisconsin Human Proteomics Symposium: Targeted Proteomics and Systems Biology in Health and Disease.

Nine nationally recognized researchers in emerging techniques for studying proteomics — the full range of proteins produced by an organism — will describe applications in cancer, cardiovascular disease, neurodegenerative disease and virology.

Presenters from UW–Madison, Vanderbilt University, Princeton University, Purdue University, UCLA and elsewhere will also describe technology development in the fast-changing field of proteomics.

“We anticipate participation by 200 to 300 conferees from academia, clinics and industry,” says Ying Ge, a symposium coordinator and director of mass spectrometry in the Human Proteomics Program at the School of Medicine and Public Health. “The schedule includes a poster session and many other opportunities for networking.”

The symposium, which is open to the public (registration fee is $90, or $45 for students and post-doctoral researchers), will be held at the BioPharmaceutical Technology Center (Promega Corp. campus), 5445 E. Cheryl Parkway, Fitchburg, Wis.

More information can be found on the BioPharmaceutical Technology Center Institute website.